Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 10Gynecologic 7Thoracic 4Genitourinary 4Dermatologic 3Head & Neck 2Endocrine 2CNS 2Other 1Lymphoid 1Classical hematology 1

Conditions

Obesity 219Neoplasms 82Mucositis 66Sexual Dysfunction, Physiological 65Breast Neoplasms 64Polycystic Ovary Syndrome 56Overweight 55Dyspnea 32Motor Activity 30Constipation 30Head and Neck Neoplasms 28Prostatic Neoplasms 25Weight Loss 24Multiple Endocrine Neoplasia Type 1 19Colorectal Neoplasms 18Pain 16Diabetes Mellitus 16Stomatitis 15Lung Neoplasms 15Opioid-Induced Constipation 14Depression 14Cardiovascular Diseases 14Insulin Resistance 13Endometrial Neoplasms 13Sexuality 11Sexual Dysfunctions, Psychological 11Diabetes Mellitus, Type 2 11Fatigue 10Anxiety Disorders 10Stomach Neoplasms 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Behavior × Other × Clear all
NCT00758108 2019-12-12

Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions

National Institutes of Health Clinical Center (CC)

Completed
197 enrolled
GenitourinaryOther

Behavior, Intellectual Disability, Wilms Tumor, Obesity, Urogenital Abnormalities, Aniridia, WAGR Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡